Filing Flows › Health Care › Pennant Group (PNTG)
Pennant Group (PNTG) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Pennant Group (PNTG) Q3 2026 earnings results →
Q3 2026 Revenue up 32% year over year to $302M · 3¢ of every $1 of revenue kept as net profit · operating margin 5.5%
Pennant Group made $302M in Q3 2026 (+32% Y/Y). Operating margin 5.5%, net earnings $9.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $302.3M in Q3 2026, up 32% year over year and up 1% from the previous quarter.
Operating profit was $16.5M, a 5.5% margin (up 1.0 points year over year). Of the extra revenue versus Q3 2025, 9% reached operating profit, above the 4% margin then. Total costs grew 31% against revenue growth of 32%. The fastest-growing cost line was Cost of revenue (+34%). Net earnings were $9.6M, up 58% year over year. The effective tax rate was 22.0%.
Operating cash flow was $25.1M (up 80% year over year), 227% of net income including minority interests. Non-cash charges added back $3.7M of depreciation and $3.3M of share-based compensation. Working capital and other items added $7.0M. Capital expenditures of $15.0M left free cash flow of $10.1M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $302M | +32% | 5.5% | $9.6M | $25.1M |
| Q2 2026 | 10-Q | Aug 5, 2026 | $298M | +36% | 5.8% | $9.1M | $21.8M |
| Q1 2026 | 10-Q | May 6, 2026 | $285M | +36% | 6.1% | $8.5M | −$3.4M |
| Q4 2025 | 10-K | Feb 26, 2026 | $289M | +53% | 6.0% | $8.6M | $21.0M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $229M | +27% | 4.5% | $6.1M | $13.9M |
| Q2 2025 | 10-Q | Aug 6, 2025 | $220M | +30% | 5.3% | $7.1M | $34.6M |
| Q1 2025 | 10-Q | May 6, 2025 | $210M | +34% | 6.0% | $7.8M | −$21.2M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
- Medicare & Medicaid — 63% of its revenue · Stated in 10-K (sentence) · source
About Pennant Group
The Pennant Group, Inc. is a leading provider of high-quality healthcare services to patients, residents, and clients of all ages, including the growing senior population, in the United States. We strive to be the provider of choice in the communities we serve through our innovative operating model and unique core values. As of December 31, 2025, we operate in multiple lines of business, including home health, hospice, and senior living services across Alabama, Arizona, California, Colorado, Georgia, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin and Wyoming. We also provide home health and hospice operational support through a management service agreement in Connecticut.
In its own words, from its 10-K, filed Feb 26, 2026.
Pennant Group against its Services-Health Services peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +32% against the peers' median +13%. Operating margin: 5.5% against the peers' median 5.5%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| PNTG Pennant Group | Q3 2026 | $302M | +32% | 5.5% |
| PRVA Privia Health Group | Q3 2026 | $657M | +13% | 3.1% |
| LFST LifeStance Health Group | Q3 2026 | $456M | +25% | 7.3% |
| PIII P3 Health Partners | Q2 2026 | $386M | +9% | 10.7% |
| INNV InnovAge Holding | Q1 FY27 | $265M | +12% | 7.6% |
| USPH U S Physical Therapy | Q3 2026 | $223M | +13% | 11.3% |
| WGS GeneDx Holdings | Q2 2026 | $114M | +11% | -15.3% |
| OMDA Omada Health | Q3 2026 | $91.3M | +34% | 5.3% |
| DCGO DocGo | Q2 2026 | $73.4M | -9% | -24.4% |
Source: Pennant Group 10-Q on SEC EDGAR · CIK 1766400 · Services-Health Services
Guidance and outlook
13F: who owns PNTG and who is buying
More on PNTG
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results